Ways Douglas Kirk bought SPRB
December 11, 2025 · Form 4 insider transaction
Ways Douglas Kirk bought 1,250 shares of Spruce Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 41 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,250
Price
$0.00
Total value
N/A
InsiderWays Douglas Kirk
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 11, 2025
Filing dateJanuary 21, 2026
Shares owned after1,250
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the total number of restricted stock units ("RSUs") vested on grant. 25% of the total number of RSUs will vest on December 15, 2026, December 15, 2027 and December 15, 2028, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date.; Each RSU represents a contingent right to receive one share of common stock of the Issuer.